<p><b>A,</b> FACS analysis of ROS generation in washed platelets treated with MTX in presence or absence of NAC/NACA. <b>B,</b> GSH/GSSG ratio and (<b>C</b>) γ‑Glutamyltransferase activity. <b>D,</b> Effect of Mito-TEMPO on MTX induced ROS generation, expressed as percentage increase in DCF fluorescence. Effect of MTX in presence or absence of NAC/NACA on components of mitochondrial electron transport chain, (<b>E</b>) Complex I-NADH: ubiquinone oxidoreductase activity (<b>F</b>) Complex II-succinate: ubiquinone oxidoreductase activity (<b>G</b>) Complex III-coenzyme Q: cytochrome c-oxidoreductase activity and (<b>H</b>) Complex IV-cytochrome c oxidase activity. Values are presented as mean ± SEM (n = 5). p*/#< 0.05, p**/##< 0.01, p***/###<...
<p>(<b>A</b>) Time course of the Mito-SOX (highly selective indicator of superoxide in live cell mit...
Recent evidence has implicated succinate-driven reverse electron transport (RET) through complex I a...
Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connote...
<p><b>A,</b> Immunoblot showing the expression of phospho-JNK in time- and concentration-dependent m...
<p>Platelets were plated on Cell-Tak coated XF96 plates, and pre-treated with etomoxir (25 μM) for 1...
<p>Effect of (<b>B</b>) Dicumarol (<b>C</b>) z-DEVD-fmk and (<b>D</b>) Mito-TEMPO on MTX induced PS ...
Reactive oxygen species (ROS) production by isolated complex I is steeply dependent on the NADH/NAD(...
<p>(A–D) Washed platelets were incubated at different temperatures for 3 h (A and B), or pre-incubat...
<p>Representative experiment of FCM analysis of PT4 culture containing GBM TICs cells incubated with...
Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connote...
<p>(A) Detection of mitochondrial ROS in live cells. Live MSCs were treated with Ara-C (100 mM for 2...
Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connote...
<div><p>Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients...
<p>Exponentially growing MDA-MB-231 and MCF-7 cells were treated with DMSO (control) or 500 nmol/L o...
<p>(A and B) Generation of ROS and (C) loss of mitochondrial membrane potential were examined by H<s...
<p>(<b>A</b>) Time course of the Mito-SOX (highly selective indicator of superoxide in live cell mit...
Recent evidence has implicated succinate-driven reverse electron transport (RET) through complex I a...
Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connote...
<p><b>A,</b> Immunoblot showing the expression of phospho-JNK in time- and concentration-dependent m...
<p>Platelets were plated on Cell-Tak coated XF96 plates, and pre-treated with etomoxir (25 μM) for 1...
<p>Effect of (<b>B</b>) Dicumarol (<b>C</b>) z-DEVD-fmk and (<b>D</b>) Mito-TEMPO on MTX induced PS ...
Reactive oxygen species (ROS) production by isolated complex I is steeply dependent on the NADH/NAD(...
<p>(A–D) Washed platelets were incubated at different temperatures for 3 h (A and B), or pre-incubat...
<p>Representative experiment of FCM analysis of PT4 culture containing GBM TICs cells incubated with...
Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connote...
<p>(A) Detection of mitochondrial ROS in live cells. Live MSCs were treated with Ara-C (100 mM for 2...
Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connote...
<div><p>Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients...
<p>Exponentially growing MDA-MB-231 and MCF-7 cells were treated with DMSO (control) or 500 nmol/L o...
<p>(A and B) Generation of ROS and (C) loss of mitochondrial membrane potential were examined by H<s...
<p>(<b>A</b>) Time course of the Mito-SOX (highly selective indicator of superoxide in live cell mit...
Recent evidence has implicated succinate-driven reverse electron transport (RET) through complex I a...
Thrombocytopenia in methotrexate (MTX)-treated cancer and rheumatoid arthritis (RA) patients connote...